-
1 Comment
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.9.
Based on the above factors, Eargo, Inc gets an overall score of 1/5.
Industry | Medical Devices |
---|---|
Sector | Healthcare |
CurrencyCode | USD |
Exchange | NASDAQ |
ISIN | US2700871096 |
Dividend Yield | 0.0% |
---|---|
Market Cap | 116M |
Beta | 1.6 |
Target Price | 2 |
PE Ratio | None |
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024